Business · 09/04/2025
FDA Clears ETHYOL (Amifostine) for Injection, 500 mg/vial
The FDA has determined that ETHYOL (amifostine) for injection, 500 mg/vial, was not withdrawn from sale due to safety or effectiveness concerns, allowing it to remain approved for use in ANDAs.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →